June 2024 newsletter out now (contains links to full versions of the Lancet Onc series!) headneckcig.org/_files/ugd/31d…

ASTRO president-elect, Neha Vapiwala, spoke with us for our latest feature where we discussed: 💡Representation and diversity in the field 💡Her top priorities for her term 💡The legacy she hopes to leave Read the full interview at 🔗👇 bit.ly/4cnTQ5a

New in #practicalRO: Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma: A Case-Based Radiosurgery Society Practice Guide. #radonc tinyurl.com/barbourpro

Looking forward to this - will be a great part of ASTRO #ASTRO24

This is pretty absurd from UnitedHealthcare EviCore By Evernorth

Wish I could say this was a surprise… (even less of a surprise that a Trump appointee made the ruling) wsj.com/us-news/law/ju…

Great commentary and agree with Katelyn Atkins, MD, PHD - when treating the thorax, we have the data to move beyond mean heart dose

Great resource! - always something we can do Winship Cancer Institute of Emory University

Congrats to my friend Yungan TAO & GORTEC for this huge trial of IO in LA HNSCC Avelumab-cetuximab inferior to cisplatin CRT in fit patients but superior to cetuximab-RT for PFS in cisplatin ineligible population. #ESMO2024

Congrats Michael Topf MD, MSCI! Well-deserved

98% PFS at 2 years in 70 Gy arm - will take really excellent selection tools to de-escalate with those results

An amazing step forward in a relatively challenging to treat disease space that hasn't seen much progress in a long time. Look forward to seeing more results from this!

Excited to speak about de-escalation in HPV+ oropharyngeal cancer and on late cardiac toxicity all in one meeting SOMERA Sociedad Mexicana de Radioterapeutas - very honored by the invite and the conference venue is truly breathtaking (Huatulco, Oaxaca)

Very sad that I could not join in Athens - looks to be an incredible meeting and hope to be in-person at the next iteration!

It was a great annual #HNCIG meeting. Thanks to everyone who participated either in Athens or online.

Melanoma Among Adult Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study out on JCO buff.ly/4jeicCV This study investigated the incidence, risk factors, and outcomes of melanoma as a subsequent malignant neoplasm among childhood cancer

This is the REAL problem with US Healthcare. Time to break them up.

Potentially practice-changing evidence for proton therapy in the treatment of oropharynx cancer.

Was a great session this morning! Honored to give a talk in this beautiful city!

Excited to help bring CIRT back to the U.S. Still a long road ahead, but proud to be part of the journey. Mayo Clinic Comprehensive Cancer Center Mayo Clinic Radiation Oncology Laura Vallow, MD